Gastroenterology
Hernia
47
Pipeline Programs↗
12
Active Trials↗
21
Companies Involved↗
Hernia is a moderately active landscape with 47 programs across 21 companies. The most active players are TLC Biopharmaceuticals, Inc., Mononuclear Therapeutics Ltd., Gynecologic Oncology Group. 13 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical18
Phase 14
Phase 29
Phase 33
Analysis
Trial Status
56
clinical trials
Completed29 · 52%
Unknown status8 · 14%
Recruiting7 · 13%
Terminated4 · 7%
Active, not recruiting3 · 5%
Withdrawn3 · 5%
Other2 · 4%
Clinical Trials
Trial Activity
56 trials
Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial
Recruiting·—·Preclinical·NCT07577414·40 enrolled
Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)
Recruiting·—·Preclinical·NCT05354505·10 enrolled
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
Active, not recruiting·—·Phase 1·NCT05177991·200 enrolled
Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia
Not yet recruiting·—·Phase 4·NCT07247240·40 enrolled
Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery
Completed·—·Phase 4·NCT00530400·1,369 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)